Disease-modifying treatments for Alzheimer's disease: a perspective based on experience with R-Flurbiprofen.

Disease-modifying treatments for Alzheimer's disease: a perspective based on experience with R-Flurbiprofen.

Bibliographic Details
Main Author:	Wilcock, G
Format:	Journal article
Language:	English
Published:	2006

Similar Items

A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study
by: Shafq Al-azzawi, et al.
Published: (2020-08-01)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Flurizan, (MPC-7869, (R)-flurbiprofen) a selective A beta-42 lowering agent in patients with mild to moderate Alzheimer's disease: A randomised, placebo-controlled, double blind trial
by: Wilcock, G, et al.
Published: (2005)

Efficacy and safety of MPC-7869 (R-flurbiprofen), a Selective AB42-Lowering Agent, in Alzheimer's disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study.
by: Laughlin, M, et al.
Published: (2006)

Treatment of the cholinergic impairment in Alzheimer's disease
by: Wilcock, G
Published: (1994)

Current approaches to the treatment of Alzheimer's disease.
by: Wilcock, G
Published: (1996)

Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective ab42-lowering agent, in mild Alzheimer's disease (AD): Results of a 12-month Phase 2 trial and 1-year follow-on study
by: Black, S, et al.
Published: (2006)

The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
by: Han Yao, et al.
Published: (2021-04-01)

New horizons for Alzheimer's disease: Potential disease-modifying anti-amyloid therapies
by: Orgogozo, J, et al.
Published: (2007)

Treatment of Alzheimer's disease: future directions.
by: Wilcock, G, et al.
Published: (1996)

Disease-modifying trials in Alzheimer's disease: a European task force consensus.
by: Vellas, B, et al.
Published: (2007)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
by: Wilcock, G
Published: (2007)

Drug treatment of Alzheimer's disease - a clinician's view point
by: Wilcock, G
Published: (1991)

Measurement and modeling of solubilities of flurbiprofen in modified supercritical carbon dioxide.
by: Chin, Gui Jin.
Published: (2009)

Neurotrophins in Alzheimer's disease
by: Wilcock, G
Published: (2002)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1993)

Enantioselective esterification of (R,S)-flurbiprofen catalyzed by lipase in ionic liquid
by: Ruihong Zhao, et al.
Published: (2017-01-01)

Hyperinsulinaemia and Alzheimer's disease.
by: Razay, G, et al.
Published: (1994)

Galantamine in Alzheimer's disease.
by: Razay, G, et al.
Published: (2008)

Alzheimer's disease--current issues.
by: Wilcock, G
Published: (1988)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1990)

Age and Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1983)

Velnacrine for Alzheimer's disease.
by: Birks, J, et al.
Published: (2004)

Treating Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1995)

Evidence-based pharmacotherapy of Alzheimer's disease.
by: Evans, J, et al.
Published: (2004)

R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids.
by: Philipp Bishay, et al.
Published: (2010-01-01)

Population pharmacokinetic modeling of flurbiprofen, the active metabolite of flurbiprofen axetil, in Chinese patients with postoperative pain
by: Zhang J, et al.
Published: (2018-11-01)

Bapineuzumab in Alzheimer's disease: where now?
by: Wilcock, G
Published: (2010)

The olfactory bulbs in Alzheimer's disease.
by: Esiri, M, et al.
Published: (1984)

The increasing burden of Alzheimer disease.
by: Sadik, K, et al.
Published: (2003)

Asymmetry of pathology in Alzheimer's disease.
by: Wilcock, G, et al.
Published: (1987)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
by: Kehoe, P, et al.
Published: (2007)

The effects of galantamine treatment on caregiver time in Alzheimer's disease.
by: Sano, M, et al.
Published: (2003)

Population Pharmacokinetic Modeling of Flurbiprofen, the Active Metabolite of Flurbiprofen Axetil, in Chinese Patients with Postoperative Pain [Corrigendum]
by: Zhang J, et al.
Published: (2020-03-01)

THE ROLE OF GROWTH-FACTORS AND NEUROPEPTIDES IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1994)

The challenge of Alzheimer's disease--no longer a silent epidemic.
by: Wilcock, G
Published: (1988)

Perspectives of Alzheimer's disease treatments.
by: Davis, J, et al.
Published: (2008)

The metabolic syndrome and Alzheimer disease.
by: Razay, G, et al.
Published: (2007)

Formulation and Evaluation of Flurbiprofen Oral Film
by: Shaimaa N. Abd-Alhammid, et al.
Published: (2017-03-01)

Formulation and Evaluation of Flurbiprofen Oral Film
by: Shaimaa N. Abd-Alhammid, et al.
Published: (2017-03-01)